Hong Kong Stock Moves: EDGE MEDICAL-B Surges Nearly 8% Again, Accelerating Domestic Substitution for Da Vinci, Overseas Installations Begin Ramping Up

Stock News08-11

EDGE MEDICAL-B (02675) rose nearly 8% again, trading up 6.83% at HK$41.3 as of press time, with a turnover of HK$22.9571 million.

On the news front, EDGE MEDICAL recently announced the completion of an investment in AI company Yuanhao Dynamics. This investment will further strengthen the company's capabilities in exploring "AI + surgical robot" intelligent surgery, laying a strategic foundation for embodied intelligent medical robot businesses. Yuanhao Dynamics focuses on the fifth-generation multimodal 4D world model, founded by a team with a Tsinghua background, with a technical direction directly aligned with "AI + surgical robot" embodied intelligence.

Huachuang Securities pointed out that in the domestic market, EDGE MEDICAL holds a leading domestic position, with its winning bid share ranking first among domestic manufacturers. As policies such as domestic service price projects and provincial-level centralized equipment procurement are implemented, the penetration rate of the domestic endoscopic surgical robot market is expected to increase rapidly. Domestic manufacturers like EDGE MEDICAL, leveraging their price advantages, are expected to further accelerate the substitution of Da Vinci systems. In overseas markets, the company's installations have begun to ramp up, the overseas supporting service system is gradually improving, and combined with the product's cost-performance advantage, the company has significant potential in non-US overseas markets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1105780694?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-11 14:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105780694","market":"us","top_or_hot":-1,"title":"Hong Kong Stock Moves: EDGE MEDICAL-B Surges Nearly 8% Again, Accelerating Domestic Substitution for Da Vinci, Overseas Installations Begin Ramping Up","media":"Stock News","content":"<p><b>EDGE MEDICAL-B (02675)</b> rose nearly 8% again, trading up 6.83% at HK$41.3 as of press time, with a turnover of HK$22.9571 million.<br><br>On the news front, <b>EDGE MEDICAL</b> recently announced the completion of an investment in AI company Yuanhao Dynamics. This investment will further strengthen the company's capabilities in exploring \"AI + surgical robot\" intelligent surgery, laying a strategic foundation for embodied intelligent medical robot businesses. Yuanhao Dynamics focuses on the fifth-generation multimodal 4D world model, founded by a team with a Tsinghua background, with a technical direction directly aligned with \"AI + surgical robot\" embodied intelligence.<br><br>Huachuang Securities pointed out that in the domestic market, <b>EDGE MEDICAL</b> holds a leading domestic position, with its winning bid share ranking first among domestic manufacturers. As policies such as domestic service price projects and provincial-level centralized equipment procurement are implemented, the penetration rate of the domestic endoscopic surgical robot market is expected to increase rapidly. Domestic manufacturers like <b>EDGE MEDICAL</b>, leveraging their price advantages, are expected to further accelerate the substitution of Da Vinci systems. In overseas markets, the company's installations have begun to ramp up, the overseas supporting service system is gradually improving, and combined with the product's cost-performance advantage, the company has significant potential in non-US overseas markets.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stock Moves: EDGE MEDICAL-B Surges Nearly 8% Again, Accelerating Domestic Substitution for Da Vinci, Overseas Installations Begin Ramping Up</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stock Moves: EDGE MEDICAL-B Surges Nearly 8% Again, Accelerating Domestic Substitution for Da Vinci, Overseas Installations Begin Ramping Up\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-11 14:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>EDGE MEDICAL-B (02675)</b> rose nearly 8% again, trading up 6.83% at HK$41.3 as of press time, with a turnover of HK$22.9571 million.<br><br>On the news front, <b>EDGE MEDICAL</b> recently announced the completion of an investment in AI company Yuanhao Dynamics. This investment will further strengthen the company's capabilities in exploring \"AI + surgical robot\" intelligent surgery, laying a strategic foundation for embodied intelligent medical robot businesses. Yuanhao Dynamics focuses on the fifth-generation multimodal 4D world model, founded by a team with a Tsinghua background, with a technical direction directly aligned with \"AI + surgical robot\" embodied intelligence.<br><br>Huachuang Securities pointed out that in the domestic market, <b>EDGE MEDICAL</b> holds a leading domestic position, with its winning bid share ranking first among domestic manufacturers. As policies such as domestic service price projects and provincial-level centralized equipment procurement are implemented, the penetration rate of the domestic endoscopic surgical robot market is expected to increase rapidly. Domestic manufacturers like <b>EDGE MEDICAL</b>, leveraging their price advantages, are expected to further accelerate the substitution of Da Vinci systems. In overseas markets, the company's installations have begun to ramp up, the overseas supporting service system is gradually improving, and combined with the product's cost-performance advantage, the company has significant potential in non-US overseas markets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1100","symbol_name":"医疗保健设备","start_time":0,"source_url":"","article_id":"1105780694","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105780694","pubTimestamp":1786428981,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"EDGE MEDICAL-B (02675) rose nearly 8% again, trading up 6.83% at HK$41.3 as of press time, with a turnover of HK$22.9571 million.On the news front, EDGE MEDICAL recently announced the completion of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1100":"医疗保健设备","VXUS":"国际股票ETF-Vanguard","BK4588":"碎股","02675":"精锋医疗-B","KSTR":"中国科技半导体科创50指数ETF-KraneShares","BK4585":"ETF&股票定投概念","KCAI":"KraneShares China Alpha Index ETF"},"translate_title":"港股走势：EDGE MEDICAL-B再次飙升近8%，加速达芬奇的国内替代，海外安装开始加速","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KSTR":1,"KCAI":1,"VXUS":1,"02675":1},"content_text":"EDGE MEDICAL-B (02675) rose nearly 8% again, trading up 6.83% at HK$41.3 as of press time, with a turnover of HK$22.9571 million.On the news front, EDGE MEDICAL recently announced the completion of an investment in AI company Yuanhao Dynamics. This investment will further strengthen the company's capabilities in exploring \"AI + surgical robot\" intelligent surgery, laying a strategic foundation for embodied intelligent medical robot businesses. Yuanhao Dynamics focuses on the fifth-generation multimodal 4D world model, founded by a team with a Tsinghua background, with a technical direction directly aligned with \"AI + surgical robot\" embodied intelligence.Huachuang Securities pointed out that in the domestic market, EDGE MEDICAL holds a leading domestic position, with its winning bid share ranking first among domestic manufacturers. As policies such as domestic service price projects and provincial-level centralized equipment procurement are implemented, the penetration rate of the domestic endoscopic surgical robot market is expected to increase rapidly. Domestic manufacturers like EDGE MEDICAL, leveraging their price advantages, are expected to further accelerate the substitution of Da Vinci systems. In overseas markets, the company's installations have begun to ramp up, the overseas supporting service system is gradually improving, and combined with the product's cost-performance advantage, the company has significant potential in non-US overseas markets.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1105780694","isCrawlerRequest":true}